C M Bidwell & Associates LTD Moderna, Inc. Transaction History

C M Bidwell & Associates LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $41,551 - $73,724	-351 Reduced 24.06%	1,108 $199,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $28,454 - $46,797	-241 Reduced 14.18%	1,459 $173,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $199,121 - $300,203	1,700 New	1,700 $243,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $166,880 - $272,328	-739 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $134,471 - $293,588	-606 Reduced 45.06%	739 $284,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $26,631 - $48,170	-205 Reduced 13.23%	1,345 $316,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $80,356 - $136,881	736 Added 90.42%	1,550 $203,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $53,512 - $138,266	814 New	814 $85,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.